4.0
Dec 20, 2023
Former employee
Recommend
CEO approval
Business Outlook
Pros
Great flagship product with a big, untapped market and growing levels of evidence. You can get easily behind the mission and feel connected to the patient impact.
Cons
The sales growth (and stock price) has been lower than target, partially due to lack of focus from the leadership.